"Antigens, CD" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation.
Descriptor ID |
D015703
|
MeSH Number(s) |
D23.050.301.264.035 D23.101.100.110
|
Concept/Terms |
Antigens, CD- Antigens, CD
- CD Antigens
- Cluster of Differentiation Markers
- Cluster of Differentiation Antigens
|
Below are MeSH descriptors whose meaning is more general than "Antigens, CD".
Below are MeSH descriptors whose meaning is more specific than "Antigens, CD".
This graph shows the total number of publications written about "Antigens, CD" by people in this website by year, and whether "Antigens, CD" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 4 | 16 | 20 |
1996 | 13 | 16 | 29 |
1997 | 14 | 9 | 23 |
1998 | 11 | 13 | 24 |
1999 | 10 | 18 | 28 |
2000 | 13 | 20 | 33 |
2001 | 15 | 20 | 35 |
2002 | 18 | 37 | 55 |
2003 | 9 | 20 | 29 |
2004 | 16 | 29 | 45 |
2005 | 8 | 35 | 43 |
2006 | 6 | 35 | 41 |
2007 | 18 | 26 | 44 |
2008 | 24 | 15 | 39 |
2009 | 13 | 22 | 35 |
2010 | 18 | 15 | 33 |
2011 | 10 | 18 | 28 |
2012 | 9 | 18 | 27 |
2013 | 10 | 18 | 28 |
2014 | 8 | 13 | 21 |
2015 | 9 | 12 | 21 |
2016 | 5 | 16 | 21 |
2017 | 5 | 8 | 13 |
2018 | 6 | 9 | 15 |
2019 | 8 | 9 | 17 |
2020 | 8 | 7 | 15 |
2021 | 3 | 6 | 9 |
2022 | 2 | 3 | 5 |
2023 | 1 | 2 | 3 |
2024 | 4 | 4 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antigens, CD" by people in Profiles.
-
Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression. Cancer Res Commun. 2024 Dec 01; 4(12):3209-3223.
-
BST2 facilitates activation of hematopoietic stem cells through ERK signaling. Exp Hematol. 2024 Dec; 140:104653.
-
LAG-3 and PD-1 synergize on CD8+ T?cells to drive T cell exhaustion and hinder autocrine IFN-?-dependent anti-tumor immunity. Cell. 2024 Aug 08; 187(16):4355-4372.e22.
-
Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunity. Cell. 2024 Aug 08; 187(16):4373-4388.e15.
-
In vivo Bruton's tyrosine kinase inhibition attenuates alcohol-associated liver disease by regulating CD84-mediated granulopoiesis. Sci Transl Med. 2024 Aug 07; 16(759):eadg1915.
-
Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis. Nat Commun. 2024 Jul 09; 15(1):5767.
-
Expression of CD6 in Aggressive NK/T-cell Neoplasms and Assessment as a Potential Therapeutic Target: A Bone Marrow Pathology Group Study. Clin Lymphoma Myeloma Leuk. 2024 Nov; 24(11):e808-e818.
-
From the archives of MD Anderson Cancer Center. Mesothelial/monocytic incidental cardiac excrescence with a review of the literature. Ann Diagn Pathol. 2024 Aug; 71:152296.
-
LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy. Cancer Res. 2023 12 15; 83(24):4047-4062.
-
Exploring the Expression of Adenosine Pathway-Related Markers CD73 and CD39 in Colorectal and Pancreatic Carcinomas Characterized by Multiplex Immunofluorescence: A Pilot Study. Pathobiology. 2024; 91(3):205-218.